Decreased MMP-9 production in primary progressive multiple sclerosis patients
about
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis.Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.Biomarkers
P2860
Decreased MMP-9 production in primary progressive multiple sclerosis patients
description
article
@en
im August 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2004
@uk
name
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@en
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@nl
type
label
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@en
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@nl
prefLabel
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@en
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@nl
P2093
P2860
P50
P1476
Decreased MMP-9 production in primary progressive multiple sclerosis patients
@en
P2093
P2860
P304
P356
10.1191/1352458504MS1058OA
P577
2004-08-01T00:00:00Z